Bioactivity:

Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010

CAS nr:

274693-27-5

Purity:

98%

Molecular Weight:

522,57

SMILES:

CCCSc1nc2c(nnn2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)c(N[C@@H]2C[C@H]2c2cc(F)c(F)cc2)n1

Formula:

C23H28F2N6O4S

Pathway:

Metabolism,Neuroscience

Target:

P450,P2 Receptor